ZVRA
NASDAQ · Pharmaceuticals
Zevra Therapeutics Inc
$12.88
+0.23 (+1.82%)
Open$12.68
Previous Close$12.65
Day High$12.97
Day Low$12.64
52W High$14.27
52W Low$7.16
Volume—
Avg Volume2.41M
Market Cap762.58M
P/E Ratio6.14
EPS$2.15
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
-58.5% upside
Current
$12.88
$12.88
Target
$5.34
$5.34
$3.67
$5.34 avg
$6.76
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 110.86M | 30.86M | 109.96M |
| Net Income | 86.66M | -124,101,933 | 24.47M |
| Profit Margin | 78.2% | -424.5% | 22.3% |
| EBITDA | -61,316,810 | -97,531,026 | 54.29M |
| Free Cash Flow | — | — | 22.49M |
| Rev Growth | +116.7% | -6.2% | -4.5% |
| Debt/Equity | 0.40 | 1.50 | 0.54 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |